Chapitre 6. The challenges and effects of digital medical devices on the doctor-patient relationship, as seen through the lens of treating sleep apnoea.

Tablets, smartphones, digital platforms, connected objects with or without Artificial Intelligence (AI) are invading our daily lives and transforming our relationships with others. Having already entered the field of wellness, in recent years we have seen the expectations and hopes raised by these new devices turn towards the field of health. In 2019, the European Parliament passed a resolution on a comprehensive European industrial policy on artificial intelligence and robotics 55, calling for caution in the use of algorithmic processes in the medical field and stressing that “the current system of approval of Digital Medical Devices may not be suitable for AI technologies”.

Antidepressant therapy in patients undergoing coronary artery bypass grafting: the MOTIV-CABG trial.

Background: The efficacy of antidepressant therapy in patients undergoing coronary artery bypass grafting (CABG) is not clearly established.

Methods: This double-blind trial was conducted at University Hospital, Besançon, France. Adult CABG patients were randomized (1:1) to receive escitalopram (10 mg daily) or placebo from 2 to 3 weeks before to 6 months after surgery, including 12 months post-surgery follow-up.